These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 9574528

  • 1. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system.
    Schwarz A, Grabbe S, Grosse-Heitmeyer K, Roters B, Riemann H, Luger TA, Trinchieri G, Schwarz T.
    J Immunol; 1998 May 01; 160(9):4262-70. PubMed ID: 9574528
    [Abstract] [Full Text] [Related]

  • 2. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D, Savir A, Bhardwaj N, Elkon KB.
    J Immunol; 1999 Nov 15; 163(10):5303-11. PubMed ID: 10553053
    [Abstract] [Full Text] [Related]

  • 3. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells.
    Zhang HG, Su X, Liu D, Liu W, Yang P, Wang Z, Edwards CK, Bluethmann H, Mountz JD, Zhou T.
    J Immunol; 1999 Feb 01; 162(3):1423-30. PubMed ID: 9973398
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM, Alard P, Liang S, Clark SL.
    Int Immunol; 2004 May 01; 16(5):697-706. PubMed ID: 15096489
    [Abstract] [Full Text] [Related]

  • 5. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W, Osaki T, Okamura H, Robbins PD, Kurimoto M, Nagata S, Lotze MT, Tahara H.
    J Immunol; 1999 Jul 15; 163(2):583-9. PubMed ID: 10395644
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells.
    Matsue H, Edelbaum D, Hartmann AC, Morita A, Bergstresser PR, Yagita H, Okumura K, Takashima A.
    J Immunol; 1999 May 01; 162(9):5287-98. PubMed ID: 10228004
    [Abstract] [Full Text] [Related]

  • 7. Role of Fas/Fas ligand-mediated apoptosis in murine contact hypersensitivity.
    Xu B, Bulfone-Paus S, Aoyama K, Yu S, Huang P, Morimoto K, Matsushita T, Takeuchi T.
    Int Immunopharmacol; 2003 Jul 01; 3(7):927-38. PubMed ID: 12810350
    [Abstract] [Full Text] [Related]

  • 8. Vaccination of apoptotic Fas ligand-expressing tumors decreased antitumor responses by enhanced production of immunosuppressive cytokines.
    Wada A, Tada Y, Shimozato O, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M.
    Anticancer Res; 2005 Jul 01; 25(1A):299-303. PubMed ID: 15816551
    [Abstract] [Full Text] [Related]

  • 9. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation.
    Lu L, Qian S, Hershberger PA, Rudert WA, Lynch DH, Thomson AW.
    J Immunol; 1997 Jun 15; 158(12):5676-84. PubMed ID: 9190916
    [Abstract] [Full Text] [Related]

  • 10. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
    Shimizu M, Fontana A, Takeda Y, Yagita H, Yoshimoto T, Matsuzawa A.
    J Immunol; 1999 Jun 15; 162(12):7350-7. PubMed ID: 10358186
    [Abstract] [Full Text] [Related]

  • 11. Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation.
    Schmitt DA, Owen-Schaub L, Ullrich SE.
    J Immunol; 1995 May 15; 154(10):5114-20. PubMed ID: 7730617
    [Abstract] [Full Text] [Related]

  • 12. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis.
    Caricchio R, Reap EA, Cohen PL.
    J Immunol; 1998 Jul 01; 161(1):241-51. PubMed ID: 9647230
    [Abstract] [Full Text] [Related]

  • 13. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
    Oberg HH, Lengl-Janssen B, Kabelitz D, Janssen O.
    Cell Immunol; 1997 Oct 10; 181(1):93-100. PubMed ID: 9344501
    [Abstract] [Full Text] [Related]

  • 14. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity.
    Shimizu M, Fontana A, Takeda Y, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jan 10; 207(1):41-8. PubMed ID: 11161452
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide sensitizes tumor cells to dendritic cell-mediated apoptosis, uptake, and cross-presentation.
    Huang J, Tatsumi T, Pizzoferrato E, Vujanovic N, Storkus WJ.
    Cancer Res; 2005 Sep 15; 65(18):8461-70. PubMed ID: 16166326
    [Abstract] [Full Text] [Related]

  • 16. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
    Yoshimoto Y, Kawada M, Ikeda D, Ishizuka M.
    Int Immunopharmacol; 2005 Feb 15; 5(2):281-8. PubMed ID: 15652759
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-CD3 induces bi-phasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T cell compartments.
    Miura N, Yamamoto M, Fukutake M, Ohtake N, Iizuka S, Ishige A, Sasaki H, Fukuda K, Yamamoto T, Hayakawa S.
    Int Immunol; 2005 May 15; 17(5):513-22. PubMed ID: 15778290
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells.
    Koppi TA, Tough-Bement T, Lewinsohn DM, Lynch DH, Alderson MR.
    Eur J Immunol; 1997 Dec 15; 27(12):3161-5. PubMed ID: 9464801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.